drugset / Trial / NCT05088733

Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia (YYFZJDTIHBVRHCIA)

NCT05088733 ↗

Phase 0 Unknown 120 enrolled Beijing Ditan Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Clinical research of Yang Yin Fu Zheng Jie Du therapy in HBV related hepatocellular carcinoma induced anemia. The purpose of this study is to observe the efficacy of routine medical care combined with Yang Yin Fu Zheng Jie Du therapy for patients belong to HBV-HCC induced anemia.

Timeline

Start
2020-07-01
Primary completion
2023-06-30
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Yang Yin Fu Zheng Jie Du therapy Traditional medicine (herbal / TCM) — —